Coverage
-
February 15, 2011
A federal judge has determined that an agreement requires Valeant Pharmaceuticals International Inc. to assume full cost-sharing obligations, including the payment of all defense costs, in product liability cases involving Eli Lilly & Co.'s discontinued Parkinson's drug Permax.
1 other articles on this case.
View all »